Performance of Bioabsorbable Vascular Scaffolds (Absorb) Compared to Xience Stents - an Optical Coherence Tomography Study
NCT02001025 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2013-12-04
Summary
The biodegradable ABSORB scaffold is characterized by a greater strut thickness, but it has a greater flexibility compared to the XIENCE stent. Due to its fragility the inflating pressure of the ABSORB scaffold is limited and suitable lesions have to be well prepared. This study assesses the incidence of malapposed stent-struts, and the frequency of stent-underexpansion and edge dissection after ABSORB implantation compared to the XIENCE stent.
Conditions
- Bioresorbable Scaffolds
Interventions
- DEVICE
-
Absorb scaffold
- DEVICE
-
Xience stent
Sponsors & Collaborators
-
Rudolf Berger
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-11-30
- Primary Completion
- 2014-12-31
Countries
- Austria
Study Locations
More Related Trials
-
Optical Coherence TomOgraphy Assessment of the Drug-Eluting Stent
NCT01012583 ·Status: UNKNOWN
-
Test Safety of Biodegradable and Permanent Limus-Eluting Stents Assessed by Optical Coherence Tomography
NCT01097434 ·Status: COMPLETED ·Phase: PHASE4
-
Optical Coherence Tomography in Long Lesions
NCT01133925 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparative Response to Vascular Injury in Patients With Diabetes Mellitus: An OCT Study of BVS Versus Xience DES
NCT03236415 ·Status: WITHDRAWN ·Phase: NA
-
COMPARE-II- Vasomotion and Imaging Substudy
NCT01329237 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Examine the Implantation Characteristics of Two Drug-Eluting Stents
NCT01201369 ·Status: COMPLETED ·Phase: NA
-
XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice
NCT02042300 ·Status: COMPLETED
-
LONG-DES VI (Drug Eluting Stent for Long Lesions in Coronary Artery)
NCT01489761 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of Everolimus-Eluting Stents (The K-XIENCE Registry)
NCT01350869 ·Status: COMPLETED
-
Late Stent Strut Apposition and Coverage After Drug-Eluting Stent Implantation by OCT in Patients With AMI
NCT02770651 ·Status: UNKNOWN
-
The ABSORB Bioresorbable Scaffold Below the Knee (BTK) Study
NCT02793349 ·Status: TERMINATED ·Phase: NA
-
Absorb BVS vs. Drug Coated Balloon for Treatment Of ISR
NCT02474485 ·Status: SUSPENDED ·Phase: NA
-
A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) System in Chinese Population ~ ABSORB CHINA Randomized Controlled Trial (RCT)
NCT01923740 ·Status: COMPLETED ·Phase: NA
-
Vessel Injury in Relation With Strut Thickness Assessed by OCT
NCT03026465 ·Status: COMPLETED ·Phase: PHASE4
-
Optical Coherence Tomography for Drug Eluting Stent Safety
NCT00693030 ·Status: UNKNOWN ·Phase: PHASE4
-
A Randomized Comparison of Long-Term Healing Between Biodegradable- Versus Durable-Polymer Everolimus Eluting Stents in STEMI
NCT03440801 ·Status: COMPLETED ·Phase: NA
-
Xience or Vision Stent Management of Angina in the Elderly
NCT02198716 ·Status: COMPLETED ·Phase: NA
-
Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents for Diffuse Long Coronary Artery Disease
NCT02831205 ·Status: TERMINATED ·Phase: PHASE4
-
PITT PCI Xience Registry
NCT01299207 ·Status: COMPLETED
-
Test Efficacy of Biodegradable and Permanent Limus-Eluting Stents
NCT01068106 ·Status: UNKNOWN ·Phase: PHASE4
-
Test Safety and Efficacy of Zotarolimus- and Everolimus-Eluting Stents (ZES/EES) Assessed by Optical Coherence Tomography
NCT01230723 ·Status: UNKNOWN ·Phase: PHASE4
-
ABSORB II Randomized Controlled Trial
NCT01425281 ·Status: COMPLETED ·Phase: NA
-
Test Efficacy With Bioresorbable Polymer Coating Versus Bioresorbable Polymer Backbone (ISAR-RESORB)
NCT02421016 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Strut Coverage With OPTIMAX Versus SYNERGY Stents
NCT02464397 ·Status: UNKNOWN ·Phase: PHASE4
-
Covered Stents in Treatment of Coronary Artery Perforation
NCT04630314 ·Status: COMPLETED